3-O-beta-D-甘露糖基D-甘露糖 | 50692-75-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 3-O-beta-D-甘露糖基D-甘露糖
• 中文别名: 3-O-β-D-甘露吡喃糖基D-甘露糖
• 英文名称: (4S,5R)-6-(hydroxymethyl)-4-[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2,3,5-triol
• CAS: 50692-75-6
• 化学式: C₁₂H₂₂O₁₁
• 分子量: 342.3
• InChiKey: QIGJYVCQYDKYDW-PKGNJHJLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -4.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  190
• 氢给体数：
  8
• 氢受体数：
  11

文献信息

• USE OF MODIFIED OLIGO-B-(1,3)-GLUCANS FOR TREATING DISEASES OF THE IMMUNE SYSTEM, OLIGO-B- (1,3V-GLUCAN-(1,3)- MANNOSE, OLIGO-B-(1,3)-GLUCAN-(1,3)- MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THEM AND MEDICAMENTS CONTAINING THEM
  申请人：Yvin Jean-Claude

  公开号：US20100286388A1

  公开（公告）日：2010-11-11

  The present invention relates to the use of at least one compound of formula (I) or (II), in which R 1 is H and n is an integer from 2 to 10, for the preparation of a medicament for treating diseases chosen from the group comprising tumour, cancer, viral disease, bacterial disease, fungal disease, disease of the immune system, auto-immune disease or disease linked to a deficiency in immunostimulation, in human beings and warm-blooded animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing them.
• USE OF MODIFIED OLIGO-B-(1,3)-GLUCANES FOR TREATING DISEASES OF THE IMMUNE SYSTEM OLIGO-B-(1,3V-GLUCANE-(1,3)-MANNOSE, OLIGO-B-(1,3)-GLUCANE-(1,3)-MANNITOL AND DERIVATIVES THEREOF, METHODS FOR PREPARING THE SAME AND DRUGS CONTAINING THEM
  申请人：ASE & BIO.

  公开号：US20130178616A1

  公开（公告）日：2013-07-11

  The present invention relates to the use of at least one compound of formula (III), (IV), (V) or (VI), in which p is an integer from 0 to 9; and R2 represents hydrogen, allyl, methylnaphthyl, benzyl, paramethoxybenzyl, or halogenoacetyl, for the preparation of a medicament for treating diseases such as tumors, cancer, viral disease, bacterial disease, fungal disease, disease of the immune system, auto-immune disease or disease linked to a deficiency in immunostimulation, in human beings and warm-blooded animals. The invention also relates to new products having a mannose or mannitol termination as well as a method for preparing them.
• US8367641B2
  申请人：——

  公开号：US8367641B2

  公开（公告）日：2013-02-05